1 Recent IPO to Add to Your Watch List

The coronavirus pandemic has made it clear that, despite all of the cutting-edge technologies in healthcare, there's still much that scientists don't know about how the human immune system works.

That's partly due to the complexity of biology and partly due to technical gaps. After all, scientists can only study what can be accurately measured -- and the diagnostic tools and sequencing processes required for quality research are still being invented and curated.

In recent years, the combination of machine learning and novel sequencing technologies has begun to remove those obstacles to knowledge and measurement. One company on the frontier is Adaptive Biotechnologies (NASDAQ: ADPT), which has wasted little time throwing its technology platform at the coronavirus pandemic. The stock has been a little volatile since its initial public offering (IPO) in July 2019, but it still deserves a spot on your watch list.

Source Fool.com